15 INDEPENDENCE BOULEVARD, SUITE 410, WARREN, NJ
Tevogen Inc. Stockholders Approve 2024 Omnibus Incentive Plan Amendment
News, Articles of Incorporation, Bylaws
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Other Events
Announces Reverse Stock Split
Tevogen Bio Holdings Inc. Approves Plan Amendment and Reverse Stock Split
Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders
Q2
Q1
FY 2025
Q3
FY 2024
Notice of Late Filing for Annual Report
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
PRE 14A
Definitive Proxy Statement
Additional Proxy Materials
PRER14A
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence
Post-Effective Amendment to Registration Statement